Vermont has become the first state to ban the dangerous herbicide paraquat, a move celebrated by public health advocates who have long warned of its links to Parkinson's disease and other serious health conditions. Governor Phil Scott signed the legislation into law on Tuesday, marking a significant step forward in protecting Vermont residents from the harmful effects of this widely used pesticide.

For decades, paraquat has been employed in the United States as a tool to control weeds in industrial agriculture. However, mounting scientific evidence, including studies by the National Institutes of Health (NIH), has revealed a disturbing correlation between paraquat exposure and an increased risk of Parkinson's disease, non-Hodgkin lymphoma, and childhood leukemia.

"There are so many factors that are pointing to the correlation … between paraquat use and Parkinson’s," said State Representative Michelle Bos-Lun during a House committee hearing. "We have to do something to phase this out. Our job is to support farmers and to support all Vermonters. My belief is that paraquat is causing harm to both."

The ban, effective November 1, will initially allow for limited exceptions for fruit-producing tree orchards, berries, and other “small fruit” crops, providing a transition period for farmers to adopt safer alternatives. The law also mandates annual data reporting on paraquat use and allocates funding for a state-funded study on alternatives to paraquat for farmers.

This victory in Vermont highlights the urgent need for a nationwide ban on paraquat. While the chemical is banned in numerous countries due to its known toxicity, it remains one of the most widely used herbicides in the United States, particularly in the cultivation of soybeans, cotton, corn, and other commodity crops. This widespread use disproportionately impacts agricultural workers and communities located near farms, who face the greatest risk of exposure.

The fight against paraquat has been an uphill battle against powerful corporate interests. Syngenta, a major manufacturer of paraquat, has long denied any link between its product and Parkinson's disease, despite mounting scientific evidence to the contrary. The company's efforts to protect its profits have come at the expense of public health.

The legal landscape is shifting, however, with over 8,000 lawsuits pending in US courts alleging a connection between paraquat exposure and Parkinson's disease. Syngenta has already settled several cases without admitting liability and is reportedly negotiating settlements in a large number of ongoing cases. In April, the company announced it would halt paraquat production and sales in the United States and other countries, though generic versions remain available from other suppliers.